UniProt functional annotation for Q8N8N7

UniProt code: Q8N8N7.

Organism: Homo sapiens (Human).
Taxonomy: Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo.
 
Function: Functions as 15-oxo-prostaglandin 13-reductase and acts on 15-keto-PGE1, 15-keto-PGE2, 15-keto-PGE1-alpha and 15-keto-PGE2-alpha with highest activity towards 15-keto-PGE2 (PubMed:19000823). Overexpression represses transcriptional activity of PPARG and inhibits adipocyte differentiation (By similarity). {ECO:0000250|UniProtKB:Q8VDQ1, ECO:0000269|PubMed:19000823}.
 
Catalytic activity: Reaction=13,14-dihydro-15-oxo-prostaglandin E2 + NAD(+) = 15- oxoprostaglandin E2 + H(+) + NADH; Xref=Rhea:RHEA:11916, ChEBI:CHEBI:15378, ChEBI:CHEBI:57400, ChEBI:CHEBI:57402, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.3.1.48; Evidence={ECO:0000269|PubMed:19000823}; PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:11918; Evidence={ECO:0000305|PubMed:19000823};
Catalytic activity: Reaction=13,14-dihydro-15-oxo-prostaglandin E2 + NADP(+) = 15- oxoprostaglandin E2 + H(+) + NADPH; Xref=Rhea:RHEA:11912, ChEBI:CHEBI:15378, ChEBI:CHEBI:57400, ChEBI:CHEBI:57402, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.3.1.48; Evidence={ECO:0000269|PubMed:19000823}; PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:11914; Evidence={ECO:0000305|PubMed:19000823};
Catalytic activity: Reaction=13,14-dihydro-15-oxo-PGF2alpha + NADP(+) = 15-oxoprostaglandin F2alpha + H(+) + NADPH; Xref=Rhea:RHEA:50588, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:133374, ChEBI:CHEBI:133409; Evidence={ECO:0000250|UniProtKB:Q8VDQ1}; PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:50590; Evidence={ECO:0000250|UniProtKB:Q8VDQ1};
Catalytic activity: Reaction=13,14-dihydro-15-oxo-prostaglandin E1 + NADP(+) = 15- oxoprostaglandin E1 + H(+) + NADPH; Xref=Rhea:RHEA:50584, ChEBI:CHEBI:15378, ChEBI:CHEBI:57401, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:133408; Evidence={ECO:0000250|UniProtKB:Q8VDQ1}; PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:50586; Evidence={ECO:0000250|UniProtKB:Q8VDQ1};
Catalytic activity: Reaction=13,14-dihydro-15-oxo-prostaglandin F1alpha + NADP(+) = 15- oxoprostaglandin F1alpha + H(+) + NADPH; Xref=Rhea:RHEA:50592, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:79072, ChEBI:CHEBI:133411; Evidence={ECO:0000250|UniProtKB:Q8VDQ1}; PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:50594; Evidence={ECO:0000250|UniProtKB:Q8VDQ1};
Biophysicochemical properties: Kinetic parameters: KM=11.21 uM for 15-keto-PGE2 {ECO:0000269|PubMed:19000823}; KM=15.87 uM for NADPH {ECO:0000269|PubMed:19000823}; Vmax=159 nmol/min/mg enzyme for 15-keto-PGE2 {ECO:0000269|PubMed:19000823}; Vmax=67 nmol/min/mg enzyme for NADPH {ECO:0000269|PubMed:19000823};
Subunit: Monomer. {ECO:0000250}.
Subcellular location: Cytoplasm {ECO:0000250}.
Tissue specificity: Widely expressed. {ECO:0000269|PubMed:15004468}.
Similarity: Belongs to the NADP-dependent oxidoreductase L4BD family. {ECO:0000305}.

Annotations taken from UniProtKB at the EBI.